904 related articles for article (PubMed ID: 8977379)
21. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
22. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.
Zhao X; Feldman D
Endocrinology; 1993 Apr; 132(4):1808-14. PubMed ID: 8384998
[TBL] [Abstract][Full Text] [Related]
23. Regulation of 1,25-dihydroxyvitamin D3 receptors by parathyroid hormone in osteoblastic cells: role of second messenger pathways.
Krishnan AV; Cramer SD; Bringhurst FR; Feldman D
Endocrinology; 1995 Feb; 136(2):705-12. PubMed ID: 7835303
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
25. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
26. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
27. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D receptor in IMR-90 human fibroblasts and antiproliferative effect of 1,25-dihydroxyvitamin D3.
Stio M; Celli A; Lunghi B; Raugei G; Modesti A; Treves C
Biochem Mol Biol Int; 1997 Dec; 43(6):1173-81. PubMed ID: 9442914
[TBL] [Abstract][Full Text] [Related]
29. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
31. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets.
Lin NU; Malloy PJ; Sakati N; al-Ashwal A; Feldman D
J Clin Endocrinol Metab; 1996 Jul; 81(7):2564-9. PubMed ID: 8675579
[TBL] [Abstract][Full Text] [Related]
32. Enhanced coactivator binding and transcriptional activation of mutant vitamin D receptors from patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets by phosphorylation and vitamin D analogs.
Liu Y; Shen Q; Malloy PJ; Soliman E; Peng X; Kim S; Pike JW; Feldman D; Christakos S
J Bone Miner Res; 2005 Sep; 20(9):1680-91. PubMed ID: 16059639
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor beta-induced dissociation between vitamin D receptor level and 1,25-dihydroxyvitamin D3 action in osteoblast-like cells.
Staal A; Birkenhäger JC; Pols HA; Buurman CJ; Vink-van Wijngaarden T; Kleinekoort WM; van den Bemd GJ; van Leeuwen JP
Bone Miner; 1994 Jul; 26(1):27-42. PubMed ID: 7950503
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
[TBL] [Abstract][Full Text] [Related]
35. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).
Liel Y; Kraus S; Levy J; Shany S
Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250
[TBL] [Abstract][Full Text] [Related]
36. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
37. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
Bula CM; Bishop JE; Ishizuka S; Norman AW
Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
[TBL] [Abstract][Full Text] [Related]
38. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
Yao J; Kathpalia P; Bushinsky DA; Favus MJ
J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
[TBL] [Abstract][Full Text] [Related]
39. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
Healy KD; Frahm MA; DeLuca HF
Arch Biochem Biophys; 2005 Jan; 433(2):466-73. PubMed ID: 15581603
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D receptor gene polymorphisms: analysis of ligand binding and hormone responsiveness in cultured skin fibroblasts.
Gross C; Musiol IM; Eccleshall TR; Malloy PJ; Feldman D
Biochem Biophys Res Commun; 1998 Jan; 242(3):467-73. PubMed ID: 9464239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]